Discussion: Women’s and Men’s Health

Case Study A 46-year-old, 230lb woman with a family history of breast cancer. She is up to date on yearly mammograms. She has a history of HTN. She complains of hot flushing, night sweats, and genitourinary symptoms. She had felt well until 1 month ago and she presented to her gynecologist for her annual gyn examination and to discuss her symptoms. She has a history of ASCUS about 5 years ago on her pap, other than that, Pap smears have been normal. Home medications are Norvasc 10mg qd and HCTZ 25mg qd. Her BP today is 150/90. She has regular monthly menstrual cycles. Her LMP was 1 month ago. Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities.Discussion: Women’s and Men’s Health For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes? For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes. Photo Credit: Getty Images To Prepare Review the Resources for this module and reflect on the different health needs and body systems presented. Your Instructor will assign you a complex case study to focus on for this Discussion. Consider how you will practice critical decision making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected. By Day 3 of Week 9 Post a brief description of your patient’s health needs from the patient case study assigned above. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.Discussion: Women’s and Men’s Health

ORDER A PLAGIARISM -FREE PAPER NOW

The advanced practitioner will experience patients with signs and symptoms that may be multiple diagnoses, and to assess the disease successfully, the professional must identify the root cause of the symptoms. The patient could undergo the early stage of the menopausal transition, triggering its signs and symptoms, depending on the details given in the scenario. The hypertension of the patient is unregulated, nevertheless, and her weight should be handled (Santoro & Johnson, 2019). The advanced practitioner gives the patient holistic treatments; pharmacotherapeutics and medications can be presented to optimize the quality care of the patient. The patient may be suffering frompre-menopause which due to her age of 46 years. The fundamental symptoms include nightsweats, hot flushing and high blood pressure.Normal menopause starts at the age of 51 or 52years. However 95% of all women normally start their menopause between the ages of 45and 55 years. This is one of her needs which should be considered by the healthcare provider.

Pharmacotherapeutics 

When a female with a previously regular cycle encounters an irregularity in her menstruation phase of 7 days or more, the early stage of the menopausal phase is entered (Santoro & Johnson, 2019). The practitioner should encourage the patient to give an exact date in an effort to confirm this issue, with the LMP being a month old. At least 12 months without a phase of emphasis could be on symptom monitoring, which may be enhanced with the treatment of patient hypertension hence it is too early to be cared for menopause. Study by Kelsberg, Maragh, & Safranek (2016) accepted that clonidine effectively decreased the occurrence of hot flashes in people with and without a breast cancer background, with less side effects of the transdermal patch than the oral tablet. With a follow-up in four weeks and the client monitoring her blood pressure regularly, clonidine transdermal 0.1 mg / d should be began on the patient. If adding the current treatments does not relieve the effects, clonidine may be an alternative in the future.

Education

The client requires education on both her medicine and her weight control; her hypertension can be improved by exercise and diet, and the risk of cardiovascular disease rises in menopausal women as the client starts the journey to menopause. Low-sodium diet learning will help the patient attain optimum personal healthcare. Study by Suckling & Swift (2015) considers considerable evidence supporting the restriction of salt to lower blood pressure and a significant percentage of evidence to support the decrease of salt in the overall population to minimize the risk of mortality from cardiovascular disease. Combined with exercise, a healthy diet will lead to weight loss and boost the general outcome of the patient whilst decreasing her blood pressure.Discussion: Women’s and Men’s Health

References

Kelsberg, G., Maragh, L., & Safranek, S. (2016). Which nonhormonal treatments are effective for hot flashes? Journal of Family Practice65(5), 1–4. Retrieved from https://search-ebscohost-com.ezp.waldenulibrary.org/login.aspx?direct=true&db=a9h&AN=115170913&site=eds-live&scope=site

Santoro, N., & Johnson, J. (2019). Diagnosing the Onset of Menopause. JAMA, The Journal of the American Medical Association, (8), 775. Retrieved from https://search-ebscohost-com.ezp.waldenulibrary.org/login.aspx?direct=true&db=edsgea&AN=edsgcl.599636292&site=eds-live&scope=site

Suckling, R. J., & Swift, P. A. (2015). The health impacts of dietary sodium and a low-salt diet. Clinical Medicine (London, England)15(6), 585–588. https://doi-org.ezp.waldenulibrary.org/10.7861/clinmedicine.15-6-585 Discussion: Women’s and Men’s Health